Loading data
QSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 375.61 m USD | 382.97 m USD | 347.95 m USD | 297.44 m USD | 151.5 m USD |
| Operating profit | -472.6 m USD | -525.21 m USD | -479.03 m USD | -420.62 m USD | -215.27 m USD |
| Interest expense | — | — | 2.38 m USD | 2.4 m USD | 1.42 m USD |
| Profit before tax | -433.51 m USD | -478.21 m USD | -445.06 m USD | — | — |
| Income tax expense | 1.54 m USD | -269 k USD | 20 k USD | — | — |
| Net income (reported basis) | -435.05 m USD | -477.86 m USD | -445.15 m USD | -411.91 m USD | -45.97 m USD |
| Net income attributable to common shareholders | -435.05 m USD | -477.86 m USD | -445.15 m USD | -411.91 m USD | -45.97 m USD |
| Basic earnings per share | -0.76 USD/share | -0.94 USD/share | -0.96 USD/share | -0.95 USD/share | -0.11 USD/share |
| Diluted earnings per share | -0.76 USD/share | -0.94 USD/share | -0.96 USD/share | -0.95 USD/share | -0.52 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.